ICL stands for "Implantable Collamer Lens." It refers to a type of corrective lens used in ophthalmology for the treatment of vision disorders such as nearsightedness (myopia), farsightedness (hyperopia), or astigmatism.
ICL is a thin, biocompatible lens made of a soft, collagen-based material known as collamer. It is designed to be implanted into the eye to correct refractive errors and improve visual acuity. It is often considered an alternative to traditional laser eye surgery procedures such as LASIK or PRK.
The ICL procedure involves a surgical insertion of the artificial lens behind the iris, but in front of the eye's natural lens. This implantation technique ensures minimal interference with the eye's natural focusing ability and accommodative functions.
Characterized by its flexibility, durability, and stability, the ICL provides refractive correction without altering the corneal shape, making it a reversible procedure. It can offer long-term vision improvement, providing greater clarity and reducing dependency on prescription glasses or contact lenses.
ICL is typically recommended for individuals with moderate to severe refractive errors, thin corneas, or unstable prescriptions. It is important for candidates to undergo a comprehensive eye examination and consultation with an ophthalmologist to determine the suitability of ICL for their specific condition.
Overall, the ICL is an innovative, minimally invasive, and effective option for vision correction, offering improved visual outcomes and quality of life for individuals seeking freedom from glasses or contact lenses.
